SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.16

773.38

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

IRIS Business Services consolidated net profit rises 2935.06% in the September 2025 quarter

Nov 15,2025

Net profit of IRIS Business Services rose 2935.06% to Rs 116.85 crore in the quarter ended September 2025 as against Rs 3.85 crore during the previous quarter ended September 2024. Sales rose 6.13% to Rs 28.56 crore in the quarter ended September 2025 as against Rs 26.91 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	28.56	26.91	6
OPM %	0.53	17.58	-
PBDT	2.60	5.20	-50
PBT	2.10	4.83	-57
NP	116.85	3.85	2935

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)